ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine

6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine

CAS No.: 1812890-23-5

Chemical Name:: 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine

Synonyms: Tofatinib Impurity 17;Tofacitinib Related Compound 23;Azilsartan medoxomil impurity319;Tofacitinib Hydrogenation Impurities;(6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-methyl-(4-methyl-piperidin-3-yl)-amine;6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine;5H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6,7-dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity)

CBNumber:: CB53143734

Molecular Formula:: C13H21N5

Molecular Weight:: 247.34

MOL File:: 1812890-23-5.mol

Modify Date:: 2024/5/20 14:01:34

Request For Quotation

6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Properties

Boiling point	435.9±45.0 °C(Predicted)
Density	1.137±0.06 g/cm3(Predicted)
solubility	Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
form	Solid
pka	9.48±0.10(Predicted)
color	Off-White to Pale Yellow

6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Chemical Properties,Uses,Production

Uses

N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine is an intermediate (reagent) in the preparation of Tofacitinib analog compounds.

6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Preparation Products And Raw materials

Raw materials

Preparation Products

6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Suppliers

Global( 36)Suppliers

Supplier	Tel	Country	ProdList	Advantage	Inquiry
ANHUI WITOP BIOTECH CO., LTD	+8615255079626	China	23555	58	Inquiry
Labnetwork lnc.	+86-27-50766799 +8618062016861	China	19994	58	Inquiry
China National Standard Pharmaceutical Corporation Limited	+8615391658522	China	11927	58	Inquiry
ShenZhen H&D Pharmaceutical Technology Co., LTD	+8618627948422	China	3389	58	Inquiry
Hubei Yangxin Medical Technology Co., Ltd.	15374522761	China	8346	55	Inquiry
PureChemland Co.,Ltd.	19936016343	China	3541	58	Inquiry
Shanghai Haohong Scientific Co., Ltd.	400-400-8210725	China	39953	58	Inquiry
Cato Research Chemicals Inc.	13342851930	China	3348	58	Inquiry
Guangzhou Juntang Technology Co., Ltd	020-36607679 13502246435	China	10951	58	Inquiry
Hunan Zengda Biological Technology Co., LTD	18711085600	China	4583	58	Inquiry

Supplier	Advantage
ANHUI WITOP BIOTECH CO., LTD	58
Labnetwork lnc.	58
China National Standard Pharmaceutical Corporation Limited	58
ShenZhen H&D Pharmaceutical Technology Co., LTD	58
Hubei Yangxin Medical Technology Co., Ltd.	55
PureChemland Co.,Ltd.	58
Shanghai Haohong Scientific Co., Ltd.	58
Cato Research Chemicals Inc.	58
Guangzhou Juntang Technology Co., Ltd	58
Hunan Zengda Biological Technology Co., LTD	58

1812890-23-5(6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine)Related Search:

Tofacitinib Impurity 2 (3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine Tofacitinib Related Compound Tofacitinib Impurity 45 Ethyl S-4-chloro-3-hydroxybutyrate

2-amino-4-fluoro-5-nitrobenzoic acid TF-A (3R,4R)-N,4-dimethyl-piperidin-3-amine (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine

Tofacitinib Impurity 20 R-afatinib 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile Tofacitinib Impurity 19

3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine

chevron_left

1of4

chevron_right

6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Related Compound 23 5H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6,7-dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]- Azilsartan medoxomil impurity319 Tofacitinib Hydrogenation Impurities (6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-methyl-(4-methyl-piperidin-3-yl)-amine Tofatinib Impurity 17 N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity) 1812890-23-5